메뉴 건너뛰기




Volumn 353, Issue 2, 2014, Pages 272-280

Metronomic cyclophosphamide schedule-dependence of innate immune cell recruitment and tumor regression in an implanted glioma model

Author keywords

Chemotherapy schedule; GL261 glioma; Innate immune response; Metronomic chemotherapy; Natural killer cells

Indexed keywords

CYCLOPHOSPHAMIDE; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 15; INTERLEUKIN 18; STROMAL CELL DERIVED FACTOR 1; TOLL LIKE RECEPTOR 7; VASCULOTROPIN A; ALKYLATING AGENT; CELL ADHESION MOLECULE; CYTOKINE;

EID: 84908669231     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.07.033     Document Type: Article
Times cited : (52)

References (59)
  • 2
    • 84881619821 scopus 로고    scopus 로고
    • Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy
    • Crawford S. Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy. Front. Pharmacol 2013, 4:68.
    • (2013) Front. Pharmacol , vol.4 , pp. 68
    • Crawford, S.1
  • 3
    • 2942615257 scopus 로고    scopus 로고
    • The anti-angiogenic basis of metronomic chemotherapy
    • Kerbel R.S., Kamen B.A. The anti-angiogenic basis of metronomic chemotherapy. Nat. Rev. Cancer 2004, 4:423-436.
    • (2004) Nat. Rev. Cancer , vol.4 , pp. 423-436
    • Kerbel, R.S.1    Kamen, B.A.2
  • 5
    • 77955172181 scopus 로고    scopus 로고
    • Metronomic chemotherapy: new rationale for new directions
    • Pasquier E., Kavallaris M., Andre N. Metronomic chemotherapy: new rationale for new directions. Nat. Rev. Clin. Oncol 2010, 7:455-465.
    • (2010) Nat. Rev. Clin. Oncol , vol.7 , pp. 455-465
    • Pasquier, E.1    Kavallaris, M.2    Andre, N.3
  • 6
    • 84877850988 scopus 로고    scopus 로고
    • Center of cancer systems biology second annual workshop - tumor metronomics: timing and dose level dynamics
    • Hahnfeldt P., Hlatky L., Klement G.L. Center of cancer systems biology second annual workshop - tumor metronomics: timing and dose level dynamics. Cancer Res 2013, 73:2949-2954.
    • (2013) Cancer Res , vol.73 , pp. 2949-2954
    • Hahnfeldt, P.1    Hlatky, L.2    Klement, G.L.3
  • 7
    • 0034032882 scopus 로고    scopus 로고
    • Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer
    • Browder T., Butterfield C.E., Kraling B.M., Shi B., Marshall B., O'Reilly M.S., et al. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res 2000, 60:1878-1886.
    • (2000) Cancer Res , vol.60 , pp. 1878-1886
    • Browder, T.1    Butterfield, C.E.2    Kraling, B.M.3    Shi, B.4    Marshall, B.5    O'Reilly, M.S.6
  • 8
    • 2542539735 scopus 로고    scopus 로고
    • A comparative analysis of low-dose metronomic cyclophosphamide reveals absent or low-grade toxicity on tissues highly sensitive to the toxic effects of maximum tolerated dose regimens
    • Emmenegger U., Man S., Shaked Y., Francia G., Wong J.W., Hicklin D.J., et al. A comparative analysis of low-dose metronomic cyclophosphamide reveals absent or low-grade toxicity on tissues highly sensitive to the toxic effects of maximum tolerated dose regimens. Cancer Res 2004, 64:3994-4000.
    • (2004) Cancer Res , vol.64 , pp. 3994-4000
    • Emmenegger, U.1    Man, S.2    Shaked, Y.3    Francia, G.4    Wong, J.W.5    Hicklin, D.J.6
  • 9
    • 84877872854 scopus 로고    scopus 로고
    • Concentration- and schedule-dependent effects of chemotherapy on the angiogenic potential and drug sensitivity of vascular endothelial cells
    • Pasquier E., Tuset M.P., Street J., Sinnappan S., MacKenzie K.L., Braguer D., et al. Concentration- and schedule-dependent effects of chemotherapy on the angiogenic potential and drug sensitivity of vascular endothelial cells. Angiogenesis 2013, 16:373-386.
    • (2013) Angiogenesis , vol.16 , pp. 373-386
    • Pasquier, E.1    Tuset, M.P.2    Street, J.3    Sinnappan, S.4    MacKenzie, K.L.5    Braguer, D.6
  • 10
    • 0034087691 scopus 로고    scopus 로고
    • Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity
    • Klement G., Baruchel S., Rak J., Man S., Clark K., Hicklin D.J., et al. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. J. Clin. Invest 2000, 105:R15-R24.
    • (2000) J. Clin. Invest , vol.105 , pp. R15-R24
    • Klement, G.1    Baruchel, S.2    Rak, J.3    Man, S.4    Clark, K.5    Hicklin, D.J.6
  • 11
    • 0037093209 scopus 로고    scopus 로고
    • Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water
    • Man S., Bocci G., Francia G., Green S.K., Jothy S., Hanahan D., et al. Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water. Cancer Res 2002, 62:2731-2735.
    • (2002) Cancer Res , vol.62 , pp. 2731-2735
    • Man, S.1    Bocci, G.2    Francia, G.3    Green, S.K.4    Jothy, S.5    Hanahan, D.6
  • 12
    • 84858799883 scopus 로고    scopus 로고
    • Cyclophosphamide-based metronomic chemotherapy: after 10 years of experience, where do we stand and where are we going?
    • Penel N., Adenis A., Bocci G. Cyclophosphamide-based metronomic chemotherapy: after 10 years of experience, where do we stand and where are we going?. Crit. Rev. Oncol. Hematol 2012, 82:40-50.
    • (2012) Crit. Rev. Oncol. Hematol , vol.82 , pp. 40-50
    • Penel, N.1    Adenis, A.2    Bocci, G.3
  • 13
    • 84901001797 scopus 로고    scopus 로고
    • Metronomics as maintenance treatment in oncology: time for chemo-switch
    • Malik P.S., Raina V., Andre N. Metronomics as maintenance treatment in oncology: time for chemo-switch. Front. Oncol 2014, 4:76.
    • (2014) Front. Oncol , vol.4 , pp. 76
    • Malik, P.S.1    Raina, V.2    Andre, N.3
  • 16
    • 79953188695 scopus 로고    scopus 로고
    • DNA alkylating therapy induces tumor regression through an HMGB1-mediated activation of innate immunity
    • Guerriero J.L., Ditsworth D., Catanzaro J.M., Sabino G., Furie M.B., Kew R.R., et al. DNA alkylating therapy induces tumor regression through an HMGB1-mediated activation of innate immunity. J. Immunol 2011, 186:3517-3526.
    • (2011) J. Immunol , vol.186 , pp. 3517-3526
    • Guerriero, J.L.1    Ditsworth, D.2    Catanzaro, J.M.3    Sabino, G.4    Furie, M.B.5    Kew, R.R.6
  • 17
    • 79953821616 scopus 로고    scopus 로고
    • Lymphadenectomy exacerbates tumor growth while lymphadenectomy plus the adoptive transfer of autologous cytotoxic cells and low-dose cyclophosphamide induces regression of an established murine fibrosarcoma
    • Maglioco A., Machuca D., Mundinano J., Cabrera G., Camicia G., Bruzzo J., et al. Lymphadenectomy exacerbates tumor growth while lymphadenectomy plus the adoptive transfer of autologous cytotoxic cells and low-dose cyclophosphamide induces regression of an established murine fibrosarcoma. Cancer Immunol. Immunother 2011, 60:389-399.
    • (2011) Cancer Immunol. Immunother , vol.60 , pp. 389-399
    • Maglioco, A.1    Machuca, D.2    Mundinano, J.3    Cabrera, G.4    Camicia, G.5    Bruzzo, J.6
  • 19
    • 77950600201 scopus 로고    scopus 로고
    • + T-cell differentiation and restores an activated polyfunctional helper phenotype
    • + T-cell differentiation and restores an activated polyfunctional helper phenotype. Blood 2010, 115:2397-2406.
    • (2010) Blood , vol.115 , pp. 2397-2406
    • Ding, Z.C.1    Blazar, B.R.2    Mellor, A.L.3    Munn, D.H.4    Zhou, G.5
  • 20
    • 70349170354 scopus 로고    scopus 로고
    • Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growth
    • van der Most R.G., Currie A.J., Cleaver A.L., Salmons J., Nowak A.K., Mahendran S., et al. Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growth. PLoS ONE 2009, 4:e6982.
    • (2009) PLoS ONE , vol.4
    • van der Most, R.G.1    Currie, A.J.2    Cleaver, A.L.3    Salmons, J.4    Nowak, A.K.5    Mahendran, S.6
  • 21
    • 84857723974 scopus 로고    scopus 로고
    • VEGF receptor inhibitors block the ability of metronomically dosed cyclophosphamide to activate innate immunity-induced tumor regression
    • Doloff J.C., Waxman D.J. VEGF receptor inhibitors block the ability of metronomically dosed cyclophosphamide to activate innate immunity-induced tumor regression. Cancer Res 2012, 72:1103-1115.
    • (2012) Cancer Res , vol.72 , pp. 1103-1115
    • Doloff, J.C.1    Waxman, D.J.2
  • 22
    • 84900395848 scopus 로고    scopus 로고
    • Intermittent metronomic drug schedule is essential for activating antitumor innate immunity and tumor xenograft regression
    • Chen C.S., Doloff J.C., Waxman D.J. Intermittent metronomic drug schedule is essential for activating antitumor innate immunity and tumor xenograft regression. Neoplasia 2014, 16:84-96.
    • (2014) Neoplasia , vol.16 , pp. 84-96
    • Chen, C.S.1    Doloff, J.C.2    Waxman, D.J.3
  • 23
    • 0021953807 scopus 로고
    • In vivo modulation of myelopoiesis and immune functions by maleic anhydride divinyl ether copolymer (MVE-2) in tumor-free and MBL-2 tumor-bearing mice treated with cyclophosphamide
    • Schlick E., Ruffmann R., Chirigos M.A., Welker R.D., Herberman R.B. In vivo modulation of myelopoiesis and immune functions by maleic anhydride divinyl ether copolymer (MVE-2) in tumor-free and MBL-2 tumor-bearing mice treated with cyclophosphamide. Cancer Res 1985, 45:1108-1114.
    • (1985) Cancer Res , vol.45 , pp. 1108-1114
    • Schlick, E.1    Ruffmann, R.2    Chirigos, M.A.3    Welker, R.D.4    Herberman, R.B.5
  • 24
    • 0023013658 scopus 로고
    • Repair processes of hemopoiesis after applying cyclophosphamide. I. Morphological changes in the bone marrow, spleen and thymus
    • Mackova N., Suliova J. Repair processes of hemopoiesis after applying cyclophosphamide. I. Morphological changes in the bone marrow, spleen and thymus. Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch 1986, 113:596-604.
    • (1986) Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch , vol.113 , pp. 596-604
    • Mackova, N.1    Suliova, J.2
  • 25
    • 68249096784 scopus 로고    scopus 로고
    • Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
    • Rodier F., Coppe J.P., Patil C.K., Hoeijmakers W.A., Munoz D.P., Raza S.R., et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat. Cell Biol 2009, 11:973-979.
    • (2009) Nat. Cell Biol , vol.11 , pp. 973-979
    • Rodier, F.1    Coppe, J.P.2    Patil, C.K.3    Hoeijmakers, W.A.4    Munoz, D.P.5    Raza, S.R.6
  • 26
    • 84902922297 scopus 로고    scopus 로고
    • Anti-tumor innate immunity activated by intermittent metronomic cyclophosphamide treatment of 9L brain tumor xenografts is preserved by anti-angiogenic drugs that spare VEGF receptor 2
    • Doloff J.C., Chen C.S., Waxman D.J. Anti-tumor innate immunity activated by intermittent metronomic cyclophosphamide treatment of 9L brain tumor xenografts is preserved by anti-angiogenic drugs that spare VEGF receptor 2. Mol. Cancer 2014, 13:158.
    • (2014) Mol. Cancer , vol.13 , pp. 158
    • Doloff, J.C.1    Chen, C.S.2    Waxman, D.J.3
  • 27
    • 0020626585 scopus 로고
    • Difference in effect of single immunosuppressive agents (cyclophosphamide, CCNU, 5-FU) on peripheral blood immune cell parameters and central nervous system immunoglobulin synthesis rate in patients with multiple sclerosis
    • Shih W.W., Baumhefner R.W., Tourtellotte W.W., Haskell C.M., Korn E.L., Fahey J.L. Difference in effect of single immunosuppressive agents (cyclophosphamide, CCNU, 5-FU) on peripheral blood immune cell parameters and central nervous system immunoglobulin synthesis rate in patients with multiple sclerosis. Clin. Exp. Immunol 1983, 53:122-132.
    • (1983) Clin. Exp. Immunol , vol.53 , pp. 122-132
    • Shih, W.W.1    Baumhefner, R.W.2    Tourtellotte, W.W.3    Haskell, C.M.4    Korn, E.L.5    Fahey, J.L.6
  • 29
    • 0037293242 scopus 로고    scopus 로고
    • Response of hematopoiesis to cyclophosphamide follows highly specific patterns in bone marrow and spleen
    • Sefc L., Psenak O., Sykora V., Sulc K., Necas E. Response of hematopoiesis to cyclophosphamide follows highly specific patterns in bone marrow and spleen. J. Hematother. Stem Cell Res 2003, 12:47-61.
    • (2003) J. Hematother. Stem Cell Res , vol.12 , pp. 47-61
    • Sefc, L.1    Psenak, O.2    Sykora, V.3    Sulc, K.4    Necas, E.5
  • 30
    • 0019181878 scopus 로고
    • Effect of chemotherapeutic agents on natural and BCG-stimulated macrophage cytotoxicity in mice
    • Mantovani A., Luini W., Candiani G.P., Spreafico F. Effect of chemotherapeutic agents on natural and BCG-stimulated macrophage cytotoxicity in mice. Int. J. Immunopharmacol 1980, 2:333-339.
    • (1980) Int. J. Immunopharmacol , vol.2 , pp. 333-339
    • Mantovani, A.1    Luini, W.2    Candiani, G.P.3    Spreafico, F.4
  • 32
    • 0033084021 scopus 로고    scopus 로고
    • IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor
    • Hyodo Y., Matsui K., Hayashi N., Tsutsui H., Kashiwamura S., Yamauchi H., et al. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. J. Immunol 1999, 162:1662-1668.
    • (1999) J. Immunol , vol.162 , pp. 1662-1668
    • Hyodo, Y.1    Matsui, K.2    Hayashi, N.3    Tsutsui, H.4    Kashiwamura, S.5    Yamauchi, H.6
  • 34
    • 60549117539 scopus 로고    scopus 로고
    • IL-15 trans-presentation promotes human NK cell development and differentiation in vivo
    • Huntington N.D., Legrand N., Alves N.L., Jaron B., Weijer K., Plet A., et al. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J. Exp. Med 2009, 206:25-34.
    • (2009) J. Exp. Med , vol.206 , pp. 25-34
    • Huntington, N.D.1    Legrand, N.2    Alves, N.L.3    Jaron, B.4    Weijer, K.5    Plet, A.6
  • 35
    • 0030265706 scopus 로고    scopus 로고
    • Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells
    • Oshimi Y., Oda S., Honda Y., Nagata S., Miyazaki S. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J. Immunol 1996, 157:2909-2915.
    • (1996) J. Immunol , vol.157 , pp. 2909-2915
    • Oshimi, Y.1    Oda, S.2    Honda, Y.3    Nagata, S.4    Miyazaki, S.5
  • 36
    • 0028962125 scopus 로고
    • Fas-mediated cytotoxicity by freshly isolated natural killer cells
    • Arase H., Arase N., Saito T. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med 1995, 181:1235-1238.
    • (1995) J. Exp. Med , vol.181 , pp. 1235-1238
    • Arase, H.1    Arase, N.2    Saito, T.3
  • 37
    • 77957157551 scopus 로고    scopus 로고
    • The multiple faces of CXCL12 (SDF-1alpha) in the regulation of immunity during health and disease
    • Karin N. The multiple faces of CXCL12 (SDF-1alpha) in the regulation of immunity during health and disease. J. Leukoc. Biol 2010, 88:463-473.
    • (2010) J. Leukoc. Biol , vol.88 , pp. 463-473
    • Karin, N.1
  • 38
    • 84872609726 scopus 로고    scopus 로고
    • Synergistical toll-like receptors activated dendritic cells induce antitumor effects against carcinoembryonic antigen-expressing colon cancer
    • Hong X., Dong T., Hu J., Yi T., Li W., Zhang Z., Lin S., Niu W. Synergistical toll-like receptors activated dendritic cells induce antitumor effects against carcinoembryonic antigen-expressing colon cancer. Int. J. Colorectal Dis 2013, 28:25-33.
    • (2013) Int. J. Colorectal Dis , vol.28 , pp. 25-33
    • Hong, X.1    Dong, T.2    Hu, J.3    Yi, T.4    Li, W.5    Zhang, Z.6    Lin, S.7    Niu, W.8
  • 39
    • 84887494213 scopus 로고    scopus 로고
    • Targeting uptake receptors on human plasmacytoid dendritic cells triggers antigen cross-presentation and robust type I IFN secretion
    • Tel J., Sittig S.P., Blom R.A., Cruz L.J., Schreibelt G., Figdor C.G., et al. Targeting uptake receptors on human plasmacytoid dendritic cells triggers antigen cross-presentation and robust type I IFN secretion. J. Immunol 2013, 191:5005-5012.
    • (2013) J. Immunol , vol.191 , pp. 5005-5012
    • Tel, J.1    Sittig, S.P.2    Blom, R.A.3    Cruz, L.J.4    Schreibelt, G.5    Figdor, C.G.6
  • 40
    • 0018142447 scopus 로고
    • Induction of macrophage production and proliferation by a purified colony stimulating factor
    • Stanley E.R., Chen D.M., Lin H.S. Induction of macrophage production and proliferation by a purified colony stimulating factor. Nature 1978, 274:168-170.
    • (1978) Nature , vol.274 , pp. 168-170
    • Stanley, E.R.1    Chen, D.M.2    Lin, H.S.3
  • 41
    • 0027407109 scopus 로고
    • Endothelial-leukocyte adhesion molecules
    • Bevilacqua M.P. Endothelial-leukocyte adhesion molecules. Annu. Rev. Immunol 1993, 11:767-804.
    • (1993) Annu. Rev. Immunol , vol.11 , pp. 767-804
    • Bevilacqua, M.P.1
  • 42
    • 0035514524 scopus 로고    scopus 로고
    • Cell adhesion molecules, leukocyte trafficking, and strategies to reduce leukocyte infiltration
    • Radi Z.A., Kehrli M.E., Ackermann M.R. Cell adhesion molecules, leukocyte trafficking, and strategies to reduce leukocyte infiltration. J. Vet. Intern. Med 2001, 15:516-529.
    • (2001) J. Vet. Intern. Med , vol.15 , pp. 516-529
    • Radi, Z.A.1    Kehrli, M.E.2    Ackermann, M.R.3
  • 43
    • 7144264398 scopus 로고    scopus 로고
    • Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice
    • Detmar M., Brown L.F., Schon M.P., Elicker B.M., Velasco P., Richard L., et al. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J. Invest. Dermatol 1998, 111:1-6.
    • (1998) J. Invest. Dermatol , vol.111 , pp. 1-6
    • Detmar, M.1    Brown, L.F.2    Schon, M.P.3    Elicker, B.M.4    Velasco, P.5    Richard, L.6
  • 44
    • 0027197245 scopus 로고
    • Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
    • Kim K.J., Li B., Winer J., Armanini M., Gillett N., Phillips H.S., et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993, 362:841-844.
    • (1993) Nature , vol.362 , pp. 841-844
    • Kim, K.J.1    Li, B.2    Winer, J.3    Armanini, M.4    Gillett, N.5    Phillips, H.S.6
  • 45
    • 0028929803 scopus 로고
    • Angiogenesis in cancer, vascular, rheumatoid and other disease
    • Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med 1995, 1:27-31.
    • (1995) Nat. Med , vol.1 , pp. 27-31
    • Folkman, J.1
  • 46
    • 80053159303 scopus 로고    scopus 로고
    • The parallel lives of angiogenesis and immunosuppression: cancer and other tales
    • Motz G.T., Coukos G. The parallel lives of angiogenesis and immunosuppression: cancer and other tales. Nat. Rev. Immunol 2011, 11:702-711.
    • (2011) Nat. Rev. Immunol , vol.11 , pp. 702-711
    • Motz, G.T.1    Coukos, G.2
  • 47
    • 34047131797 scopus 로고    scopus 로고
    • Vascular endothelial growth factor and immunosuppression in cancer: current knowledge and potential for new therapy
    • Johnson B.F., Clay T.M., Hobeika A.C., Lyerly H.K., Morse M.A. Vascular endothelial growth factor and immunosuppression in cancer: current knowledge and potential for new therapy. Expert Opin. Biol. Ther 2007, 7:449-460.
    • (2007) Expert Opin. Biol. Ther , vol.7 , pp. 449-460
    • Johnson, B.F.1    Clay, T.M.2    Hobeika, A.C.3    Lyerly, H.K.4    Morse, M.A.5
  • 48
    • 54249133961 scopus 로고    scopus 로고
    • Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands
    • Wendel M., Galani I.E., Suri-Payer E., Cerwenka A. Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands. Cancer Res 2008, 68:8437-8445.
    • (2008) Cancer Res , vol.68 , pp. 8437-8445
    • Wendel, M.1    Galani, I.E.2    Suri-Payer, E.3    Cerwenka, A.4
  • 49
    • 0037943965 scopus 로고    scopus 로고
    • Lack of dendritic cell mobilization into the peripheral blood of cancer patients following standard- or high-dose chemotherapy plus granulocyte-colony stimulating factor
    • Ferrari S., Rovati B., Porta C., Alessandrino P.E., Bertolini A., Collova E., et al. Lack of dendritic cell mobilization into the peripheral blood of cancer patients following standard- or high-dose chemotherapy plus granulocyte-colony stimulating factor. Cancer Immunol. Immunother 2003, 52:359-366.
    • (2003) Cancer Immunol. Immunother , vol.52 , pp. 359-366
    • Ferrari, S.1    Rovati, B.2    Porta, C.3    Alessandrino, P.E.4    Bertolini, A.5    Collova, E.6
  • 50
    • 70350108862 scopus 로고    scopus 로고
    • Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination
    • Radojcic V., Bezak K.B., Skarica M., Pletneva M.A., Yoshimura K., Schulick R.D., et al. Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination. Cancer Immunol. Immunother 2010, 59:137-148.
    • (2010) Cancer Immunol. Immunother , vol.59 , pp. 137-148
    • Radojcic, V.1    Bezak, K.B.2    Skarica, M.3    Pletneva, M.A.4    Yoshimura, K.5    Schulick, R.D.6
  • 51
    • 84862980672 scopus 로고    scopus 로고
    • Residual dormant cancer stem-cell foci are responsible for tumor relapse after antiangiogenic metronomic therapy in hepatocellular carcinoma xenografts
    • Martin-Padura I., Marighetti P., Agliano A., Colombo F., Larzabal L., Redrado M., et al. Residual dormant cancer stem-cell foci are responsible for tumor relapse after antiangiogenic metronomic therapy in hepatocellular carcinoma xenografts. Lab. Invest 2012, 92:952-966.
    • (2012) Lab. Invest , vol.92 , pp. 952-966
    • Martin-Padura, I.1    Marighetti, P.2    Agliano, A.3    Colombo, F.4    Larzabal, L.5    Redrado, M.6
  • 52
    • 45949087412 scopus 로고    scopus 로고
    • Low-dose metronomic cyclophosphamide treatment mediates ischemia-dependent K-ras mutation in colorectal carcinoma xenografts
    • Shahrzad S., Shirasawa S., Sasazuki T., Rak J.W., Coomber B.L. Low-dose metronomic cyclophosphamide treatment mediates ischemia-dependent K-ras mutation in colorectal carcinoma xenografts. Oncogene 2008, 27:3729-3738.
    • (2008) Oncogene , vol.27 , pp. 3729-3738
    • Shahrzad, S.1    Shirasawa, S.2    Sasazuki, T.3    Rak, J.W.4    Coomber, B.L.5
  • 53
    • 84874753845 scopus 로고    scopus 로고
    • A comprehensive gene expression analysis of resistance formation upon metronomic cyclophosphamide therapy
    • Kubisch R., Meissner L., Krebs S., Blum H., Gunther M., Roidl A., et al. A comprehensive gene expression analysis of resistance formation upon metronomic cyclophosphamide therapy. Transl. Oncol 2013, 6:1-9.
    • (2013) Transl. Oncol , vol.6 , pp. 1-9
    • Kubisch, R.1    Meissner, L.2    Krebs, S.3    Blum, H.4    Gunther, M.5    Roidl, A.6
  • 54
    • 77950916340 scopus 로고    scopus 로고
    • In vivo chemoresistance of prostate cancer in metronomic cyclophosphamide therapy
    • Thoenes L., Hoehn M., Kashirin R., Ogris M., Arnold G.J., Wagner E., et al. In vivo chemoresistance of prostate cancer in metronomic cyclophosphamide therapy. J. Proteomics 2010, 73:1342-1354.
    • (2010) J. Proteomics , vol.73 , pp. 1342-1354
    • Thoenes, L.1    Hoehn, M.2    Kashirin, R.3    Ogris, M.4    Arnold, G.J.5    Wagner, E.6
  • 55
    • 78650991789 scopus 로고    scopus 로고
    • Tumors that acquire resistance to low-dose metronomic cyclophosphamide retain sensitivity to maximum tolerated dose cyclophosphamide
    • Emmenegger U., Francia G., Chow A., Shaked Y., Kouri A., Man S., et al. Tumors that acquire resistance to low-dose metronomic cyclophosphamide retain sensitivity to maximum tolerated dose cyclophosphamide. Neoplasia 2011, 13:40-48.
    • (2011) Neoplasia , vol.13 , pp. 40-48
    • Emmenegger, U.1    Francia, G.2    Chow, A.3    Shaked, Y.4    Kouri, A.5    Man, S.6
  • 56
    • 46749156706 scopus 로고    scopus 로고
    • Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins
    • Guix M., Faber A.C., Wang S.E., Olivares M.G., Song Y., Qu S., et al. Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins. J. Clin. Invest 2008, 118:2609-2619.
    • (2008) J. Clin. Invest , vol.118 , pp. 2609-2619
    • Guix, M.1    Faber, A.C.2    Wang, S.E.3    Olivares, M.G.4    Song, Y.5    Qu, S.6
  • 57
    • 21744437791 scopus 로고    scopus 로고
    • Repopulation of cancer cells during therapy: an important cause of treatment failure
    • Kim J.J., Tannock I.F. Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat. Rev. Cancer 2005, 5:516-525.
    • (2005) Nat. Rev. Cancer , vol.5 , pp. 516-525
    • Kim, J.J.1    Tannock, I.F.2
  • 58
    • 65649087840 scopus 로고    scopus 로고
    • A review of mechanisms of circumvention and modulation of chemotherapeutic drug resistance
    • O'Connor R. A review of mechanisms of circumvention and modulation of chemotherapeutic drug resistance. Curr. Cancer Drug Targets 2009, 9:273-280.
    • (2009) Curr. Cancer Drug Targets , vol.9 , pp. 273-280
    • O'Connor, R.1
  • 59
    • 33751300540 scopus 로고    scopus 로고
    • RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4-hydroperoxycyclophosphamide
    • Moreb J.S., Mohuczy D., Ostmark B., Zucali J.R. RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4-hydroperoxycyclophosphamide. Cancer Chemother. Pharmacol 2007, 59:127-136.
    • (2007) Cancer Chemother. Pharmacol , vol.59 , pp. 127-136
    • Moreb, J.S.1    Mohuczy, D.2    Ostmark, B.3    Zucali, J.R.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.